immunova   Report issue

For profit Phase 3
Founded: New Canaan CT United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2017
NCT03388216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Inmunova S.A.